Login to Your Account

Pain Therapeutics, King Enter Potential $400M Remoxy Deal

By Karen Pihl-Carey

Friday, November 11, 2005
With strong Phase III data in hand, Pain Therapeutics Inc. partnered its pain drug Remoxy with King Pharmaceuticals Inc. in a deal worth up to $400 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription